Osteoporosis causes: Difference between revisions
Jump to navigation
Jump to search
Line 179: | Line 179: | ||
*[[Boyd-Stearns syndrome]] | *[[Boyd-Stearns syndrome]] | ||
*[[Brown-Sequard Syndrome]] | *[[Brown-Sequard Syndrome]]<ref name="pmid1431871">{{cite journal |author=Saltzstein RJ, Hardin S, Hastings J |title=Osteoporosis in spinal cord injury: using an index of mobility and its relationship to bone density |journal=J Am Paraplegia Soc |volume=15 |issue=4 |pages=232–4 |year=1992 |month=October |pmid=1431871 |doi= |url=}}</ref> | ||
*[[Calcium deficiency]] | *[[Calcium deficiency]] | ||
Line 201: | Line 201: | ||
*[[Chronic renal failure]]<ref name="pmid787723">{{cite journal |author=Parfitt AM |title=The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis |journal=Metab. Clin. Exp. |volume=25 |issue=10 |pages=1157–88 |year=1976 |month=October |pmid=787723 |doi= |url=}}</ref> | *[[Chronic renal failure]]<ref name="pmid787723">{{cite journal |author=Parfitt AM |title=The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis |journal=Metab. Clin. Exp. |volume=25 |issue=10 |pages=1157–88 |year=1976 |month=October |pmid=787723 |doi= |url=}}</ref> | ||
*[[Copper deficiency]] | *[[Copper deficiency]]<ref name="pmid22025246">{{cite journal |author=Nojiri H, Saita Y, Morikawa D, ''et al.'' |title=Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking |journal=J. Bone Miner. Res. |volume=26 |issue=11 |pages=2682–94 |year=2011 |month=November |pmid=22025246 |doi=10.1002/jbmr.489 |url=}}</ref> | ||
*[[Crohn's disease]] | *[[Crohn's disease]] | ||
Line 209: | Line 209: | ||
*[[Cushing's syndrome]]<ref name="pmid22450549">{{cite journal |author=Lekva T, Ueland T, Bøyum H, Evang JA, Godang K, Bollerslev J |title=TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover |journal=Eur. J. Endocrinol. |volume=166 |issue=6 |pages=1039–48 |year=2012 |month=June |pmid=22450549 |doi=10.1530/EJE-11-1082 |url=}}</ref> | *[[Cushing's syndrome]]<ref name="pmid22450549">{{cite journal |author=Lekva T, Ueland T, Bøyum H, Evang JA, Godang K, Bollerslev J |title=TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover |journal=Eur. J. Endocrinol. |volume=166 |issue=6 |pages=1039–48 |year=2012 |month=June |pmid=22450549 |doi=10.1530/EJE-11-1082 |url=}}</ref> | ||
*[[Cyproterone]] | *[[Cyproterone]]<ref name="pmid12877306">{{cite journal |author=Grasswick LJ, Bradford JM |title=Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports |journal=J. Forensic Sci. |volume=48 |issue=4 |pages=849–55 |year=2003 |month=July |pmid=12877306 |doi= |url=}}</ref><ref name="pmid11469484">{{cite journal |author=Vasireddy S, Swinson DR |title=Male osteoporosis associated with longterm cyproterone treatment |journal=J. Rheumatol. |volume=28 |issue=7 |pages=1702–3 |year=2001 |month=July |pmid=11469484 |doi= |url=}}</ref> | ||
*[[Cystathionine beta-synthase deficiency]] | *[[Cystathionine beta-synthase deficiency]] |
Revision as of 05:30, 21 July 2012
Osteoporosis Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Osteoporosis causes On the Web |
American Roentgen Ray Society Images of Osteoporosis causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti,M.B.B.S.[3]
Causes
Common Causes
- Aging
- Alcoholism
- Anorexia nervosa
- Calcium deficiency
- Chronic renal failure
- Female athlete triad
- Gonadal dysgenesis
- Hyperparathyroidism
- Hyperthyroidism
- Hypophosphatemic rickets
- Idiopathic
- Immobility
- Menopause
- Mixed connective tissue disease
- Paget's disease of bone
- Prednisolone
- Primary hypoparathyroidism
Causes by Organ System
Causes in Alphabetical Order
|
|
|
References
- ↑ Padova G, Borzì G, Incorvaia L; et al. (2011). "Prevalence of osteoporosis and vertebral fractures in acromegalic patients". Clin Cases Miner Bone Metab. 8 (3): 37–43. PMC 3279059. PMID 22461828. Unknown parameter
|month=
ignored (help) - ↑ Goswami M, Verma M, Singh A, Grewal H, Kumar G (2009). "Albright hereditary osteodystrophy: a rare case report". J Indian Soc Pedod Prev Dent. 27 (3): 184–8. doi:10.4103/0970-4388.57101. PMID 19841552.
- ↑ Legrand E, Hoppé E, Bouvard B, Audran M (2012). "[Osteoporosis in men]". Rev Prat (in French). 62 (2): 193–7. PMID 22408860. Unknown parameter
|month=
ignored (help) - ↑ Krysiak R, Okopień B (2012). "[Pathogenesis and clinical presentation of andropause]". Pol. Merkur. Lekarski (in Polish). 32 (187): 70–3. PMID 22400185. Unknown parameter
|month=
ignored (help) - ↑ Saltzstein RJ, Hardin S, Hastings J (1992). "Osteoporosis in spinal cord injury: using an index of mobility and its relationship to bone density". J Am Paraplegia Soc. 15 (4): 232–4. PMID 1431871. Unknown parameter
|month=
ignored (help) - ↑ Parfitt AM (1976). "The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis". Metab. Clin. Exp. 25 (10): 1157–88. PMID 787723. Unknown parameter
|month=
ignored (help) - ↑ Nojiri H, Saita Y, Morikawa D; et al. (2011). "Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking". J. Bone Miner. Res. 26 (11): 2682–94. doi:10.1002/jbmr.489. PMID 22025246. Unknown parameter
|month=
ignored (help) - ↑ Lekva T, Ueland T, Bøyum H, Evang JA, Godang K, Bollerslev J (2012). "TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover". Eur. J. Endocrinol. 166 (6): 1039–48. doi:10.1530/EJE-11-1082. PMID 22450549. Unknown parameter
|month=
ignored (help) - ↑ Grasswick LJ, Bradford JM (2003). "Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports". J. Forensic Sci. 48 (4): 849–55. PMID 12877306. Unknown parameter
|month=
ignored (help) - ↑ Vasireddy S, Swinson DR (2001). "Male osteoporosis associated with longterm cyproterone treatment". J. Rheumatol. 28 (7): 1702–3. PMID 11469484. Unknown parameter
|month=
ignored (help) - ↑ Gold DT, Solimeo S (2006). "Osteoporosis and depression: a historical perspective". Curr Osteoporos Rep. 4 (4): 134–9. PMID 17112423. Unknown parameter
|month=
ignored (help) - ↑ Dytfeld J, Horst-Sikorska W (2012). "Pregnancy associated osteoporosis--a case report". Ginekol. Pol. 83 (5): 377–9. PMID 22708337. Unknown parameter
|month=
ignored (help)